Polar Capital’s Aptose Biosciences, Inc. APTO Stock Holding History

Polar Capital’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$10.8M	Buy	4,012 +1,172	+41%	+$2.92M	0.08%	175
2020 Q2	$8.06M	Sell	2,840 -4,269	-60%	-$13.8M	0.07%	185
2020 Q1	$19M	Buy	7,109 +5,665	+392%	+$16.9M	0.2%	128
2019 Q4	$3.69M	Buy	+1,444	New	+$1.88M	0.03%	246

Other funds holding APTO

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Polar Capital's APTO Position: Q3 2020 in Review

Polar Capital increased its Aptose Biosciences, Inc. (APTO) stake by 41% in Q3 2020, buying an estimated $2.92M and bringing the position to 4,012 shares worth $10.8M. The position accounts for 0.08% of the portfolio, ranked #175.

Polar Capital first reported a position in APTO in Q4 2019 and has held it in 4 quarters since. The position peaked at $19M in Q1 2020. 64 funds tracked by Wall St. Rank hold APTO as of Q3 2020.

Polar Capital held 4,012 shares of Aptose Biosciences, Inc. worth $10.8M as of Q3 2020.
Polar Capital bought 1,172 Aptose Biosciences, Inc. shares in Q3 2020, an estimated $2.92M.
Aptose Biosciences, Inc. made up 0.08% of Polar Capital's portfolio in Q3 2020, its #175 holding.
Polar Capital first reported a position in Aptose Biosciences, Inc. in Q4 2019 and has held it in 4 quarters since.
Polar Capital's Aptose Biosciences, Inc. position peaked at $19M in Q1 2020.
64 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.